Vahagn C. Nikolian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vahagn C. Nikolian has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Scott E. Regenbogen
University of Michigan Health System
3 shared publications- Anna E. Boniakowski
Department of Surgery, University of Michigan Health System, 2207 Taubman Center, 1500 E. Medical Center Dr., Ann Arbor, MI, USA, 48109-5346
2 shared publications - Danielle C. Sutzko
Univ Alabama Birmingham, Dept Surg, Birmingham, AL USA
2 shared publications - Gurjit Sandhu
Department of Surgery, University of Michigan, Ann Arbor, USA
2 shared publications - Hasan Badre Alam
Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
2 shared publications - Julie Thompson-Burdine
Department of Surgery, University of Michigan, Ann Arbor, Michigan
2 shared publications
Latest Publications
- 11 August 2020
- Published by Springer Nature
- p. 667-674
Complications: Early Anastomotic Complications—Leak, Abscess, and Bleeding
- 11 August 2020
- Published by Springer Nature
- p. 667-674
Complications: Early Anastomotic Complications—Leak, Abscess, and Bleeding
- 1 April 2020
- Published by Elsevier in The American Journal of Surgery
- Vol. 219 (4) , 608-612
Greater faculty familiarity with residents improves intraoperative entrustment
- 1 April 2020
- Published by Elsevier in The American Journal of Surgery
- Vol. 219 (4) , 608-612
Greater faculty familiarity with residents improves intraoperative entrustment
- 1 February 2019
- Published by Elsevier in The American Journal of Surgery
- Vol. 217 (2) , 276-280
Bridging the gap: The intersection of entrustability and perceived autonomy for surgical residents in the OR
- 1 February 2019
- Published by Elsevier in The American Journal of Surgery
- Vol. 217 (2) , 276-280
Bridging the gap: The intersection of entrustability and perceived autonomy for surgical residents in the OR
- 8 January 2019
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 32 (01) , 016-024
Statewide Clinic Registries: The Michigan Surgical Quality Collaborative
Regional clinical registries provide a unique opportunity for shared learning and population-based analyses of the quality of surgical care. Through the “Michigan Model” of pay for participation in strategic Value Partnerships, exemplified by the Michigan Surgical Quality Collaborative (MSQC), the state's dominant private insurer, Blue Cross Blue Shield of Michigan, has sponsored 20 statewide clinical quality improvement collaboratives. MSQC represents a partnership among 73 Michigan hospitals with a robust data infrastructure and flexible platform for the promulgation of best practices in surgical quality improvement. This article will describe the organizational structure of the MSQC, the contributions the registry has made to quality improvement in colorectal surgery, and how future work will align to improve the reliability of improvement-relevant registry data.
- 8 January 2019
- Published by Georg Thieme Verlag KG in Clinics in Colon and Rectal Surgery
- Vol. 32 (01) , 016-024
Statewide Clinic Registries: The Michigan Surgical Quality Collaborative
Regional clinical registries provide a unique opportunity for shared learning and population-based analyses of the quality of surgical care. Through the “Michigan Model” of pay for participation in strategic Value Partnerships, exemplified by the Michigan Surgical Quality Collaborative (MSQC), the state's dominant private insurer, Blue Cross Blue Shield of Michigan, has sponsored 20 statewide clinical quality improvement collaboratives. MSQC represents a partnership among 73 Michigan hospitals with a robust data infrastructure and flexible platform for the promulgation of best practices in surgical quality improvement. This article will describe the organizational structure of the MSQC, the contributions the registry has made to quality improvement in colorectal surgery, and how future work will align to improve the reliability of improvement-relevant registry data.
- 15 May 2018
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 35 (10) , 1185-1191
Valproic Acid Treatment Decreases Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels in Swine Subjected to Traumatic Brain Injury
The primary aim of this study was to examine the effects of valproic acid (VPA) treatment on serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NF-L) levels. To achieve this aim, we obtained serum samples from: (1) ten Yorkshire swine subjected to controlled cortical impact (CCI) TBI + polytrauma and randomized to receive either normal saline (NS) + VPA (n=5) or NS alone (n=5) and (2) five additional swine subjected to CCI TBI without polytrauma and treated with VPA. GFAP and NF-L levels were measured in samples obtained from baseline until 10 days post-injury using a digital immunoassay from Quanterix Corporation. We found that elevated GFAP and NF-L levels were first detected at 2 hours post-injury; and peaked at 24 hours and 72 hours respectively. GFAP levels returned to baseline levels by day-10, while NF-L remained elevated at day-10. In TBI + polytrauma swine, the magnitude and duration of biomarker elevation, quantified by the area under the biomarker concentration versus time curve during the first 10-days (AUC0-10days), was higher in the NS group compared to the VPA group. For GFAP, the AUC0-10days was 45,535 (IQR: 35,741–105,711) and 22,837 [IQR: 8,082–46,627] for the NS and NS+VPA groups respectively. For NF-L, the AUC0-10days was 43,073 [IQR: 18,739–120,794] and 4,475 [2,868–11,157] for the NS and NS+VPA groups respectively. Twenty-four hour GFAP and NFL levels had the strongest correlation with lesion size and time to normalization of behavior. Accordingly, we conclude that treatment with VPA results in significantly lower serum GFAP and NF-L levels. The time-point at which GFAP and NF-L levels have the strongest correlation with outcome is 24 hours post-injury.
- 15 May 2018
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 35 (10) , 1185-1191
Valproic Acid Treatment Decreases Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels in Swine Subjected to Traumatic Brain Injury
The primary aim of this study was to examine the effects of valproic acid (VPA) treatment on serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NF-L) levels. To achieve this aim, we obtained serum samples from: (1) ten Yorkshire swine subjected to controlled cortical impact (CCI) TBI + polytrauma and randomized to receive either normal saline (NS) + VPA (n=5) or NS alone (n=5) and (2) five additional swine subjected to CCI TBI without polytrauma and treated with VPA. GFAP and NF-L levels were measured in samples obtained from baseline until 10 days post-injury using a digital immunoassay from Quanterix Corporation. We found that elevated GFAP and NF-L levels were first detected at 2 hours post-injury; and peaked at 24 hours and 72 hours respectively. GFAP levels returned to baseline levels by day-10, while NF-L remained elevated at day-10. In TBI + polytrauma swine, the magnitude and duration of biomarker elevation, quantified by the area under the biomarker concentration versus time curve during the first 10-days (AUC0-10days), was higher in the NS group compared to the VPA group. For GFAP, the AUC0-10days was 45,535 (IQR: 35,741–105,711) and 22,837 [IQR: 8,082–46,627] for the NS and NS+VPA groups respectively. For NF-L, the AUC0-10days was 43,073 [IQR: 18,739–120,794] and 4,475 [2,868–11,157] for the NS and NS+VPA groups respectively. Twenty-four hour GFAP and NFL levels had the strongest correlation with lesion size and time to normalization of behavior. Accordingly, we conclude that treatment with VPA results in significantly lower serum GFAP and NF-L levels. The time-point at which GFAP and NF-L levels have the strongest correlation with outcome is 24 hours post-injury.
- 1 May 2018
- Published by AME Publishing Company in mHealth
- Vol. 4 (5) , 11
The role of telemedicine in postoperative care
Telemedicine has become one of the most rapidly-expanding components of the health care system. Its adoption has afforded improved access to care, greater resource efficiency, and decreased costs associated with traditional office visits and has been well established in a wide array of fields. Telemedicine has been adopted in several domains of surgical care. In recent years, the role of telemedicine in postoperative care has caught attention as it has demonstrated excellent clinical outcomes, enhanced patient satisfaction, increased accessibility along with reduced wait times, and cost savings for patients and health care systems. In this narrative review, we describe the history of telemedicine, its adoption in the field of surgery and its various modalities, its use in the postoperative setting, and the potential benefits to both patients and healthcare systems. As telemedicine continues to emerge as a powerful tool for health care delivery, we also discuss several barriers to its widespread adoption as well as the future utility of telemedicine in postoperative care.
- 1 May 2018
- Published by AME Publishing Company in mHealth
- Vol. 4 (5) , 11
The role of telemedicine in postoperative care
Telemedicine has become one of the most rapidly-expanding components of the health care system. Its adoption has afforded improved access to care, greater resource efficiency, and decreased costs associated with traditional office visits and has been well established in a wide array of fields. Telemedicine has been adopted in several domains of surgical care. In recent years, the role of telemedicine in postoperative care has caught attention as it has demonstrated excellent clinical outcomes, enhanced patient satisfaction, increased accessibility along with reduced wait times, and cost savings for patients and health care systems. In this narrative review, we describe the history of telemedicine, its adoption in the field of surgery and its various modalities, its use in the postoperative setting, and the potential benefits to both patients and healthcare systems. As telemedicine continues to emerge as a powerful tool for health care delivery, we also discuss several barriers to its widespread adoption as well as the future utility of telemedicine in postoperative care.
- 1 February 2018
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 84 (2) , 386-392
Tubastatin A prevents hemorrhage-induced endothelial barrier dysfunction
Background: Microvascular hyperpermeability resulting from endothelial barrier dysfunction (EBD) is associated with worse clinical outcomes in trauma-induced hemorrhagic shock. We have previously shown that treatment with Tubastatin A (TubA), a histone deacetylase 6 inhibitor, improves outcomes in animal models of shock. In this study, we investigate whether TubA treatment may prevent trauma-related EBD. Methods: Wistar-Kyoto rats subjected to 40% hemorrhage were treated with TubA or vehicle control. Acute lung injury (ALI) was assessed histologically from tissues harvested 6 hours posthemorrhage. In vitro, human umbilical vein endothelial cells (HUVECs) were cultured in EGM BulletKit medium. Medium was exchanged for glucose-free Dulbecco’s Modified Eagle Medium (0.5% fetal bovine serum) with or without TubA, and cells were placed in an anoxic chamber (5% CO2, 95% N2, 20–48 hours). Expression of acetylated tubulin and hypoxia-inducible factor 1α was measured by Western blot. Soluble Intercellular Adhesion Molecule-1 concentration within the medium, a marker of endothelial integrity, was determined using enzyme-linked immunosorbent assay. Monolayers were assessed for permeability via transwell assays using fluorescein isothiocyanate-labeled albumin. Results: Rats treated with TubA had significantly reduced ALI relative to vehicle control. In vitro, TubA significantly attenuated anoxia-induced hyperpermeability, hypoxia-inducible factor 1α expression, and glycocalyx shedding. Conclusions: Our findings demonstrate that TubA prevents hemorrhage-induced ALI in rats. Additionally, we have shown that TubA prevents anoxia-induced EBD in vitro. Taken together, these results suggest that TubA could attenuate microvascular hyperpermeability related to hemorrhagic shock.
- 1 February 2018
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 84 (2) , 386-392
Tubastatin A prevents hemorrhage-induced endothelial barrier dysfunction
Background: Microvascular hyperpermeability resulting from endothelial barrier dysfunction (EBD) is associated with worse clinical outcomes in trauma-induced hemorrhagic shock. We have previously shown that treatment with Tubastatin A (TubA), a histone deacetylase 6 inhibitor, improves outcomes in animal models of shock. In this study, we investigate whether TubA treatment may prevent trauma-related EBD. Methods: Wistar-Kyoto rats subjected to 40% hemorrhage were treated with TubA or vehicle control. Acute lung injury (ALI) was assessed histologically from tissues harvested 6 hours posthemorrhage. In vitro, human umbilical vein endothelial cells (HUVECs) were cultured in EGM BulletKit medium. Medium was exchanged for glucose-free Dulbecco’s Modified Eagle Medium (0.5% fetal bovine serum) with or without TubA, and cells were placed in an anoxic chamber (5% CO2, 95% N2, 20–48 hours). Expression of acetylated tubulin and hypoxia-inducible factor 1α was measured by Western blot. Soluble Intercellular Adhesion Molecule-1 concentration within the medium, a marker of endothelial integrity, was determined using enzyme-linked immunosorbent assay. Monolayers were assessed for permeability via transwell assays using fluorescein isothiocyanate-labeled albumin. Results: Rats treated with TubA had significantly reduced ALI relative to vehicle control. In vitro, TubA significantly attenuated anoxia-induced hyperpermeability, hypoxia-inducible factor 1α expression, and glycocalyx shedding. Conclusions: Our findings demonstrate that TubA prevents hemorrhage-induced ALI in rats. Additionally, we have shown that TubA prevents anoxia-induced EBD in vitro. Taken together, these results suggest that TubA could attenuate microvascular hyperpermeability related to hemorrhagic shock.
- Top Cited Papers
Anastomotic leak after colorectal resection: A population-based study of risk factors and hospital variation
- 1 September 2016
- Published by Springer Nature
- p. 187-191
Surgical Strategies in Trauma